JENKEM TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.3 CNY | +4.97% |
|
+10.22% | -22.65% |
| Apr. 09 | Shanghai stocks end higher, investors cautious ahead US inflation and China data | RE |
| Apr. 09 | China stocks edge lower, investors cautious ahead US inflation and China data | RE |
| Sales 2023 | 299M 41.27M | Sales 2024 * | 363M 50.13M | Capitalization | 4.99B 688M |
|---|---|---|---|---|---|
| Net income 2023 | 123M 16.98M | Net income 2024 * | 161M 22.22M | EV / Sales 2023 | 21.6 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 13.7 x |
| P/E ratio 2023 |
52.4
x | P/E ratio 2024 * |
30.9
x | Employees | 252 |
| Yield 2023 * |
1.07% | Yield 2024 * |
-
| Free-Float | 38.57% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.97% | ||
| 1 week | +10.22% | ||
| Current month | +11.38% | ||
| 1 month | +8.50% | ||
| 3 months | +1.22% | ||
| 6 months | -28.12% | ||
| Current year | -22.65% |
1 week
72.50
83.01
1 month
71.1092.43
Current year
60.71107.47
1 year
60.71135.85
3 years
60.71403.07
5 years
60.71403.07
10 years
60.71403.07
| Managers | Title | Age | Since |
|---|---|---|---|
Xuan Zhao
CEO | Chief Executive Officer | 59 | 04-12-31 |
Li Jie Yang
CHM | Chairman | 56 | 01-10-08 |
Lei Han
DFI | Director of Finance/CFO | 36 | 19-07-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lei Han
DFI | Director of Finance/CFO | 36 | 19-07-15 |
Xuan Zhao
CEO | Chief Executive Officer | 59 | 04-12-31 |
Gang Li
BRD | Director/Board Member | 47 | 15-07-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 82.3 | +4.97% | 618,603 |
| 24-04-25 | 78.4 | +0.13% | 414,370 |
| 24-04-24 | 78.3 | +3.45% | 634,330 |
| 24-04-23 | 75.69 | +0.81% | 587,312 |
| 24-04-22 | 75.08 | +0.55% | 414,616 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Jenkem Technology Co Ltd is a company mainly engaged in research and development, production and sales of polyethylene glycol and its active derivatives. The Company's primary products are medical polyethylene glycol and its active derivatives, which are used in research, development and production of drugs and medial devices, scientific research institutions and other fields. The Company is also involved in providing technical services, including patent and non-patent technology licensing services, as well as research and development services.
Sector
Specialty Chemicals
Calendar
2024-04-29
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
82.3
CNY
Average target price
106
CNY
Spread / Average Target
+28.80%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.65% | 688M | |
| -1.62% | 19.88B | |
| -12.25% | 5.32B | |
| +4.34% | 4B | |
| +1.89% | 1.32B | |
| -5.86% | 1.14B | |
| +25.19% | 996M | |
| -14.91% | 674M | |
| -17.53% | 277M | |
| -1.84% | 260M |
- Stock Market
- Equities
- 688356 Stock
